CTLA-4 T cells immune targeted therapy based and status of transformation research in non-small cell lung cancer
YU Zongyang
MO Xiangyang
OUYANG Xuenong
Abstract：Cytotoxic T lymphocyte associated( CTLA?4) is a kind of leukocyte differentiation antigens, it participates in the negative regulation of immune response. As the treatment of non?small cell lung cancer ( NSCLC) model by the driver gene targeted therapy to immune targeted therapy,CDLA?4 has become a new research hotspot. This article combing CDLA?4 research of NSCLC in recent years and reviews the connecting with the related basic and clinical research progress.
Keywords：Non-small cell lung cancerImmune targeted therapyCytotoxic T lymphocyte-associated antigen-4T cell
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 376-379 )